Delivery Order SPE2DB22D1002-SPE2DB25FKSY5

Award Date 10/16/24
Potential Completion Date 10/17/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GARDASIL 9 vaccine syringes, a pharmaceutical product used to prevent certain types of human papillomavirus (HPV) infections. The contract has a ceiling value of $20,339.98 and is a firm fixed-price contract with an ultimate completion date of September 19, 2024. Amerisourcebergen, a major...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Gardasil 9 syringes, a vaccine for the prevention of certain types of human papillomavirus. The contract is a firm-fixed-price delivery order with a ceiling value of $3,494.92 and a period of performance through January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,088.01, is for the delivery of GARDASIL 9 syringes (0.5mL) with a completion date of November 18, 2024. The contract is a delivery order under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 syringes, a vaccine product, with a ceiling value of $26,345.93 and a completion date of December 12, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award with a delivery order valued at $10,408.51, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 syringes, a vaccine product, with a completion date of November 29, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of GARDASIL 9 vaccine syringes, a pharmaceutical product, with a ceiling value of $3,479.80 and a period of performance through April 3, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes. The $32,335.60 firm-fixed-price contract has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,124.75, is for the supply of GARDASIL 9 syringes, a vaccine product. The contract has a firm fixed-price pricing structure and a completion date of November 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $3,899.64 and a completion date of January 14, 2025. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of GARDASIL 9 vaccine syringes. The contract has a ceiling value of $9,374.38 and a completion date of July 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, that enables the government to efficiently procure a comprehensive range of medical...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKSY5
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of GARDASIL 9 vaccine syringes, a 0.5 ML single-dose human papillomavirus vaccine. The delivery order has a ceiling value of $7,734.36 and a completion date of October 17, 2024. No set-aside requirements were specified for this contract. Amerisourcebergen, a for-profit organization, has been a key vendor for federal healthcare programs, particularly supporting military and veterans' medical needs through its broad portfolio of pharmaceutical and medical supply offerings. This contract award is part of the company's broader partnership with the DLA Troop Support Medical, which facilitates the procurement of essential medical commodities across various therapeutic areas for federal government agencies and healthcare facilities.

Generated 1/15/25, 9:30 AM